Facebook Linkedin RSS Twitter Youtube
Home 2024

Gene transfer technologies

Electroporation in Cell Therapy
Artificial Intelligence

Electroporation in Cell Therapy

Overcoming Viral Vector Risks
Bioprocessing

Overcoming Viral Vector Risks

Legend Biotech Obtains Electroporation Technology License from MaxCyte Covering Cell-Based Therapies
News

Legend Biotech Obtains Electroporation Technology License from MaxCyte Covering Cell-Based Therapies

On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthrough
GEN Edge

On the Charge: MaxCyte Celebrates Role in Sickle Cell Therapy Breakthrough

Improving Flow through the Cell Therapies Bottleneck
Bioprocessing

Improving Flow through the Cell Therapies Bottleneck

Unlocking the Potential of Electroporation for Studying Ion Channel-Related Disorders and iPSCs
Genome Editing

Unlocking the Potential of Electroporation for Studying Ion Channel-Related Disorders and iPSCs

Low-Cost, Single-Cell Electroporation
Bioprocessing

Low-Cost, Single-Cell Electroporation

Case Study: Genetic Engineering of Adoptive Cell Therapies
Drug Discovery

Case Study: Genetic Engineering of Adoptive Cell Therapies

MaxCyte Signs B Cell Platform Agreement with Walking Fish Therapeutics
Cancer

MaxCyte Signs B Cell Platform Agreement with Walking Fish Therapeutics

Nature’s Needle: Feng Zhang’s Team Re-engineers Bacterial “Syringes” for Programmable Protein Delivery
Drug Discovery

Nature’s Needle: Feng Zhang’s Team Re-engineers Bacterial “Syringes” for Programmable Protein Delivery

1234Page 1 of 4
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.